Apria Healthcare Group released a statement denying yesterday's New York Post story about the medical equipment manufacturer being on the sales block.
"As a matter of policy Apria does not comment on rumors and speculation concerning possible transactions involving the Company. However, in light of speculative trading in Apria stock following publication of a New York Post story, Apria is making an exception to its policy on this occasion," the statement read.
The stock opened at 32 on Thursday, from Wednesday's close at 27.06. It closed around 29.81 on Thursday.
The statement continued: "At this time, there is no transaction pending and Apria is not engaged in any effort looking to, or negotiations with any party concerning, a sale of the Company."
The New York Post article stated that the firm had retained the Banc of America Securities to assist in the sales process. Reuters subsequently picked up the story and cited the Post.
Apria declined to comment further.